In simple terms, nolva competes and blocks the estrogen resceptor. It prevents gyno by stoping aromatized AAS from binding. Arimidex/liquidex actually prevents the aromitization of the AAS inot estrogen. This makes it a better choice for many reasons, but its also more costly.